According to Align Technology 's latest financial reports the company's current revenue (TTM) is $3.86 B. In 2022 the company made a revenue of $3.73 B a decrease over the years 2021 revenue that were of $3.95 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $3.86 B | 3.42% |
2022 | $3.73 B | -5.51% |
2021 | $3.95 B | 59.9% |
2020 | $2.47 B | 2.71% |
2019 | $2.40 B | 22.39% |
2018 | $1.96 B | 33.47% |
2017 | $1.47 B | 36.44% |
2016 | $1.07 B | 27.72% |
2015 | $0.84 B | 11.01% |
2014 | $0.76 B | 15.37% |
2013 | $0.66 B | 17.89% |
2012 | $0.56 B | 16.74% |
2011 | $0.47 B | 23.92% |
2010 | $0.38 B | 23.95% |
2009 | $0.31 B | 2.75% |
2008 | $0.30 B | 6.91% |
2007 | $0.28 B | 37.79% |
2006 | $0.20 B | -0.37% |
2005 | $0.20 B | 19.84% |
2004 | $0.17 B | 40.83% |
2003 | $0.12 B | 68.91% |
2002 | $72.65 M | 56.64% |
2001 | $46.38 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Danaher DHR | $23.89 B | 518.55% | ๐บ๐ธ USA |
3M MMM | $32.68 B | 746.16% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | $3.96 B | 2.66% | ๐บ๐ธ USA |
Biolase
BIOL | $49.16 M | -98.73% | ๐บ๐ธ USA |